NIDA to conduct research on RespireRx compounds to treat drug abuse and addiction Jan. 20, 2016 No Comments
University of Pennsylvania Treatment Research Center to begin phase II study of NS-2359 Dec. 22, 2015 No Comments
FDA approves Vistogard to treat overdose or severe toxicities due to 5-FU or capecitabine Dec. 14, 2015 No Comments
Pluristem and Fukushima Medical University sign MOU for collaboration to study PLX-R18 for ARS Dec. 7, 2015 No Comments
FDA decides not to approve Indivior's naloxone nasal spray for opioid overdose Nov. 25, 2015 No Comments
RSS